Medicaments Containing Hormones or Steroids
Código 300490 (Harmonized System 2012 by 6 digits)
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionCiudad de México: US$1.25B, State with the Most International Sales (2024)
United States: US$997M, Main commercial destination (2024)
In 2024, the states with the highest international sales in Medicaments Containing Hormones or Steroids were Ciudad de México (US$1.25B), Morelos (US$339M), Jalisco (US$163M), Estado de México (US$130M), and Baja California (US$53M).
In 2024, the countries with the most international purchases from Mexico were United States (US$997M), Canada (US$233M), Colombia (US$159M), Panama (US$83.2M), and Brazil (US$67.5M).
International Purchases
#permalink to sectionCiudad de México: US$3.1B, State with the Most International Purchases (2024)
Germany: US$707M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Medicaments Containing Hormones or Steroids were Ciudad de México (US$3.1B), Estado de México (US$475M), Jalisco (US$75.5M), Morelos (US$72.5M), and Chihuahua (US$48.6M).
The countries with the most international sales to Mexico in 2024 were Germany (US$707M), United States (US$487M), Ireland (US$321M), Italy (US$305M), and Switzerland (US$296M).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Hormones or Steroids and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Hormones or Steroids. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.35%, Mexican share in global exports - 2022
- 0.6%, Mexican share in global imports - 2022
The visualizations show the global market for Medicaments Containing Hormones or Steroids. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Hormones or Steroids were N/A. In the same year, the main importing countries for Medicaments Containing Hormones or Steroids were United States (US$68.4B), Germany (US$28.5B), and Switzerland (US$26.6B).